Cough Syrup Market to Reach at High CAGR in Forecast till 2026

Global Cough Syrup Market: Information by Product Type (Combination {Dextromethorphan + Guaifenesin, Guaifenesin + Pseudoephedrine and Brompheniramine + Pseudoephedrine} and Individual {Dextromethorphan, Guaifenesin, Ambroxol and Codeine}), by Category (Cough Suppressants and Expectorants), by Application (Adults and Children) and by Region ( Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2026​

​The new research from Ameco Research on ​Global Cough Syrup Market Report for 2026 intends to offer target audience with the fresh outlook on market and fill in the knowledge gaps with the help of processed information and opinions from industry experts. The information in the research report is well-processed and a report is accumulated by industry professionals and seasoned experts in the field to ensure of the quality of research.

The research is backed by extensive and in-depth secondary research which involves reference to various statistical databases, national government documents, relevant patent and regulatory databases, news articles, press releases, company annual reports, webcasts, financial reports, and a number of internal and external proprietary databases. This estimated data is cross-checked with industry experts from various leading companies in the market. After the entire authentication process, these reports are shared with subject matter experts (SMEs) for adding further value and to gain their insightful opinion on the research. With such robust process of data extraction, verification, and finalization, we firmly endorse the quality of our research. With such extensive and in-depth research and comprehensive coverage of information, it is always a possibility of clients finding their desired information in the report with enclosure of key components and valuable statistics in all regards.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/178042

Market analysis

Nowadays, intensifying air contamination is appearing as a driver for the growth of the market. Air pollution is a major environment-related health threat that stands as a risk component for both acute and chronic respiratory illnesses. Concurring to a report by the Forum of International Respiratory Societies (FIRS), tobacco smoke, indoor air pollution from burning fuels, and air pollution from traffic and industrial sources are highlighted as the primary contributing factors for most respiratory circumstances. During February 2019, Merck invested USD 70 million to expand its research & development (R&D) facility in Billerica, Massachusetts for the development of innovative clinical pipeline products. World Health Organization (WHO) estimated that 4.3 million deaths per year could be ascribed to indoor air pollution. Most diseases and deaths that can be attributed to protracted exposure to poor indoor air quality occurs primarily in women and children, especially in low-income families. Exposure to indoor smoke used for heating and cooking leads to COPD, lung cancer, and, in children, it causes pneumonia and asthma. This sizable population involved with respiratory ailments due to air pollution is pushing the market for cough syrup market as it is a crucial medicine used for the therapy of such diseases. The increasing incidence of respiratory disorders along with the rising air pollution are some of the key factors supporting to the growth of the cough syrup market. Additionally, the expanding geriatric population, along with an active pharmaceutical sector, are boosting market growth as aged people are more prone to respiratory disorders. Furthermore, the market is expected to corroborate lucrative growth owing to ever-increasing product improvements.

Market segmentation

The Global cough syrup market has been segmented by type, application product type, category, application and by region. The individual product type has been beyond apportioned into dextromethorphan, guaifenesin, ambroxol, and codeine. In December 2016, it was noted that Pfizer, Inc., launched a series of products as a line expansion under the Corex brand name. The first launch was on December 2016, and following releases were conducted in 2017. These designs were duly endorsed by central and state regulators. Based on the category, the market has been segmented into cough suppressants and cough syrup. And by application, the cough syrup market has been classified as adults and children. Then in July 2018, Johnson & Johnson acquired Zarbee's Naturals, a drug-free children's cough syrup. The Americas is projected to hold a full share of the global cough syrup market, and the regional market is forecasted to register a CAGR of 3.16% during the forecast period. The presence of significant market players in the region, strategic acquisitions by major players to augment product selection, cumulative cases of respiratory disorders, and availability of advanced medications for the treatment of chronic obstructive pulmonary disease (COPD) is expected to drive the market development in this region to battle these concerns effectively through the use of cough syrups. This enabled the company to expand its product portfolio globally. Combination product type has been further categorized as dextromethorphan + guaifenesin, guaifenesin + pseudoephedrine, and brompheniramine + pseudoephedrine. Based on product type, the market has been isolated into combination and entities.

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market-report/global-cough-syrup-market-2026-178042

Regional analysis
​
Geographically, Global cough syrup market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The Middle East & Africa cough syrup market has been segmented into major two regions, the Middle East and Africa. The established nations in the region, such as the UAE and Saudi Arabia, are the ones with the highest share of the cough syrup market. The advancing healthcare transportation, expanding healthcare expenditure, and increasing per capita disposable incomes of the people in these countries are some reasons leading to the large share of the market in these countries. Africa is the minimum built region with limited healthcare resources and services for the people. The low growth rate due to less created and less efficient health systems is hampering the growth of the market. Asia-Pacific is estimated to be the fastest-growing market due to the constant development in emerging countries such as India and China. High occurrence of respiratory disorders due to tobacco smoke, experience to air pollutants at home and the workplace, vehicular pollution, and indoor air pollution from biological agents related to moist and mold additional upsurge the risk of respiratory disease in children and adults in these nations. Europe accounts for the second largest, in the global cough syrup market, majorly due to the presence of key players such as Novartis, GlaxoSmithKline, and Reckitt Benckiser Group PLC. The cough syrup market in Europe is likely to be propelled by the expansion of the pharmaceutical business in Germany, France, and the UK.

Major players
​
The proposed spectators in the Global cough syrup market are cough syrup manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global cough syrup market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global cough syrup market are companies like Acella Pharmaceuticals, LLC (US), Pfizer, Inc. (US), Novartis AG (Switzerland), Merck KGaA (US), GlaxoSmithKline PLC (UK), Procter & Gamble (US), Reckitt Benckiser Group PLC (UK), Abbott (US), Sanofi (France) and Johnson & Johnson Services, Inc. (US).

Available customization:

With the given market information, Ameco research offers customization's in line with the company's specific wishes. The following customization choices unit of measurement accessible for the report:
Regional and country-level analysis of the Global Cough Syrup Market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Cough Syrup Market Research Report Forecast to 2026
​
​1 Executive Summary

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Market Structure

2.4 Development of cough syrup

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Rising Prevalence of Chronic Respiratory Disease

4.2.2 Increasing Geriatric Population

4.2.3 Rising Air Pollution

4.3 Restraints

4.3.1 Stringent Regulatory Framework

4.3.2 Product Recall

4.4 Opportunity

4.4.1 Entering Developing Economies

4.5 Macroeconomics

5 Market Factor Analysis

5.1 Supply/Value Chain Analysis

5.1.1 Raw Material Procurement

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 End Users

5.2 Porter’s Five Forces Model

5.2.1 Threat of New Entrants

5.2.2 Bargaining Power of Suppliers

5.2.3 Bargaining Power of Buyers

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Cough Syrup Cost of Production Analysis

5.3.1 Cost Overview

5.3.2 Raw Material Cost Analysis

5.3.3 Labor Cost Analysis

5.4 Manufacturers by Region

5.4.1 Americas

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Middle East & Africa

5.5 Plant Locations

6 Global Cough Syrup Market, by Category

6.1 Introduction

6.2 Cough Suppressants

6.3 Expectorants

7 Global Cough Syrup Market, by Product Type

7.1 Introduction

7.2 Americas

7.2.1 Dextromethorphan

7.2.2 Guaifenesin

7.2.3 Ambroxol

7.2.4 Phenylephrine

7.2.5 Acetaminophen

7.2.6 Diphenhydramine

7.2.7 Pholcodine

7.2.8 Pseudoephedrine

7.2.9 Codeine

7.2.10 Combination Drugs

7.2.11 Others

7.3 Europe

7.3.1 Dextromethorphan

7.3.2 Guaifenesin

7.3.3 Ambroxol

7.3.4 Phenylephrine

7.3.5 Acetaminophen

7.3.6 Diphenhydramine

7.3.7 Pholcodine

7.3.8 Pseudoephedrine

7.3.9 Codeine

7.3.10 Combination Drugs

7.3.11 Others

7.4 Asia-Pacific

7.4.1 Chlorpheniramine + Codeine

7.4.2 Levosalbutamol + Ambroxol + Guaifenesin

7.4.3 Phenylephrine + CPM + Dextromethorphan

7.4.4 Chlorpheniramine + Dextromethorphan

7.4.5 Paracetamol + Phenylephrine + Chlorpheniramine

7.4.6 Guaifenesin + Terbutaline + Bromhexine

7.4.7 Guaifenesin + Terbutaline + Ambroxol

7.4.8 Phenylephrine + Chlorpheniramine

7.4.9 Ammonium + CPM + Dextromethorphan + Guaifenesin

7.4.10 Bromhexine + Dextromethorphan + Ammonium Chloride

7.4.11 Individual Drug

7.4.12 Others

7.5 Middle East & Africa

7.5.1 Dextromethorphan + Guaifenesin

7.5.2 Dextromethorphan + Diphenhydramine Hydrochloride + Pseudoephedrine

7.5.3 Guaifenesin + Pseudoephedrine

7.5.4 Chlorpheniramine Maleate + Paracetamol + Pseudoephedrine

7.5.5 Chlorpheniramine + Phenylepherine

7.5.6 Brompheniramine + Pseudoephedrine

7.5.7 Pseudoephedrine + Triprolidin

7.5.8 Carbenoxamine + Pseudoephedrine

7.5.9 Loratadine + Pseudoephedrine

7.5.10 Individual Drugs

7.5.11 Others

8 Global Cough Syrup Market, by Application

8.1 Introduction

8.2 Adults

8.3 Children

9 Global Cough syrup Market, by Region

9.1 Overview

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Germany

9.3.2 France

9.3.3 UK

9.3.4 Italy

9.3.5 Spain

9.3.6 Russia

9.3.7 Benelux

9.3.8 Poland

9.3.9 Romania

9.3.10 Rest of Europe

9.4 Asia-Pacific

9.4.1 China

9.4.2 Japan

9.4.3 India

9.4.4 Australia

9.4.5 South East Asia

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.1.1 Saudi Arabia

9.5.1.2 Egypt

9.5.1.3 Rest of Middle East

9.5.2 Africa

9.5.2.1 Algeria

9.5.2.2 Sudan

9.5.2.3 Morocco

9.5.2.4 Libya

9.5.2.5 Tunisia

9.5.2.6 Rest of Africa

10 Competitive Landscape

10.1 Introduction

10.2 Key Developments & Growth Strategies

10.2.1 Mergers & Acquisitions

10.2.2 Agreements

10.3 Expansion

10.4 Product Launch

11 Company Profile

11.1 Pfizer, Inc.

11.1.1 Company Overview

11.1.2 Financial Overview

11.1.3 Products/Services Offered

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategies

11.2 Novartis AG

11.2.1 Company Overview

11.2.2 Financial Overview

11.2.3 Products/Services Offered

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Merck KGaA

11.3.1 Company Overview

11.3.2 Financial Overview

11.3.3 Products/Services Offered

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Johnson & Johnson Services, Inc.

11.4.1 Company Overview

11.4.2 Financial Overview

11.4.3 Products/Services Offered

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.6 Key Strategies

11.5 GlaxoSmithKline PLC

11.5.1 Company Overview

11.5.2 Financial Overview

11.5.3 Products/Services Offered

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 Acella Pharmaceuticals, LLC

11.6.1 Company Overview

11.6.2 Financial Overview

11.6.3 Products/Services Offered

11.6.4 SWOT Analysis

11.6.5 Key Strategies

11.7 Procter & Gamble

11.7.1 Company Overview

11.7.2 Financial Overview

11.7.3 Products/Services Offered

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Reckitt Benckiser Group PLC

11.8.1 Company Overview

11.8.2 Financial Overview

11.8.3 Products/Services Offered

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

11.9 Abbott

11.9.1 Company Overview

11.9.2 Financial Overview

11.9.3 Products/Services Offered

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategies

11.1 Sanofi

11.10.1 Company Overview

11.10.2 Financial Overview

11.10.3 Products/Services Offered

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

12 Appendix

12.1 References

12.2 Related Reports

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/178042

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:
Email: sales@amecoresearch.com| Call: + 1 407 915 4157